Amado Rafael (CIK 0001662119)

Latest company ownership

Shares held
541,946
Last filed at
Oct 11, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
17,237
Last filed at
Aug 7, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 8, 2025 Aug 12, 2025 Zai Lab Ltd Officer Sell 32.5 -3,000 -6.64% ✓ $105K
Apr 3, 2025 Apr 7, 2025 Zai Lab Ltd Officer Sell 22.5 -3,029 -6.28% ✗ $100.3K
Apr 1, 2025 Apr 3, 2025 Zai Lab Ltd Officer Sell 20.0 -7,541 -14.98% ✗ $270.7K
Mar 17, 2025 Mar 19, 2025 Zai Lab Ltd Officer Sell 28.8 -3,000 -8.87% ✓ $115.2K
Dec 30, 2024 Jan 2, 2025 Zai Lab Ltd Officer Sell 22.5 -7,583 -18.31% ✗ $199.3K
Aug 12, 2024 Aug 14, 2024 Zai Lab Ltd Officer Sell 25.0 -3,115 -13.24% ✓ $50.5K
Apr 3, 2024 Apr 5, 2024 Zai Lab Ltd Officer Sell 26.3 -1,952 -7.66% ✗ $30.6K
Mar 15, 2024 Mar 19, 2024 Zai Lab Ltd Officer Sell 28.8 -2,544 -11.24% ✓ $48K
Dec 29, 2023 Jan 3, 2024 Zai Lab Ltd Officer Sell 20.0 -19,363 -46.10% ✗ $509.2K
Oct 7, 2022 Oct 11, 2022 Allogene Therapeutics, Inc. EVP of R&D Sell 82.5 +10,656 2.01% ✗ $100.1K
Oct 3, 2022 Oct 5, 2022 Allogene Therapeutics, Inc. EVP of R&D Sell 42.5 -8,968 -1.66% ✗ $99.2K
Aug 2, 2022 Aug 2, 2022 Allogene Therapeutics, Inc. EVP of R&D and CMO Sell 52.5 -2,000 -0.37% ✓ $23.9K
Jul 5, 2022 Jul 6, 2022 Allogene Therapeutics, Inc. EVP of R&D and CMO Sell 52.5 -2,000 -0.37% ✓ $22.9K
Jun 21, 2022 Jun 22, 2022 Allogene Therapeutics, Inc. EVP of R&D and CMO Sell 52.5 -2,000 -0.37% ✓ $22.4K
May 19, 2022 May 19, 2022 Allogene Therapeutics, Inc. EVP of R&D and CMO Sell 42.5 -11,500 -2.06% ✗ $85.1K
Mar 15, 2022 Mar 17, 2022 Allogene Therapeutics, Inc. EVP of R&D and CMO Sell 46.3 -5,169 -1.59% ✗ $39.8K
Oct 1, 2021 Oct 4, 2021 Allogene Therapeutics, Inc. EVP of R&D and CMO Sell 40.0 -11,507 -3.43% ✗ $280.2K
Mar 15, 2021 Mar 17, 2021 Allogene Therapeutics, Inc. EVP of R&D and CMO Sell 42.5 -2,798 -2.48% ✗ $106.5K
Oct 7, 2020 Oct 8, 2020 Allogene Therapeutics, Inc. EVP of R&D and CMO Sell 22.5 -16,538 -12.90% ✓ $651.5K
Oct 1, 2020 Oct 2, 2020 Allogene Therapeutics, Inc. EVP of R&D and CMO Sell 40.0 -9,752 -7.07% ✗ $354.7K
Aug 6, 2019 Aug 7, 2019 Adaptimmune Therapeutics PLC President Sell 46.3 -11,043 -39.05% ✗ $22.7K
Jan 14, 2019 Jan 16, 2019 Adaptimmune Therapeutics PLC President Sell 46.3 -3,028 -37.84% ✗ $16.3K